{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:52:47Z","timestamp":1780408367812,"version":"3.54.1"},"reference-count":4,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.liebertpub.com\/nv\/resources-tools\/text-and-data-mining-policy\/121\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Child and Adolescent Psychopharmacology"],"published-print":{"date-parts":[[2023,9,1]]},"DOI":"10.1089\/cap.2023.0029","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T09:50:01Z","timestamp":1695117001000},"page":"295-296","source":"Crossref","is-referenced-by-count":3,"title":["Re: \u201cA Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder\u201d by Strawn et al.\u2014Concerning Harm\u2013Benefit Ratio in a Recent Trial About Escitalopram for Generalized Anxiety Disorder"],"prefix":"10.1177","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4659-9314","authenticated-orcid":false,"given":"Martin","family":"Pl\u00f6derl","sequence":"first","affiliation":[{"name":"Center for Inpatient Psychotherapy and Crisis Intervention, Paracelsus Medical University Salzburg, Salzburg, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Horowitz","sequence":"additional","affiliation":[{"name":"Research and Development Department, Goodmayes Hospital, North East London NHS Foundation Trust, Ilford, United Kingdom."},{"name":"Division of Psychiatry, University College London, London, United Kingdom (honorary affiliation)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Hengartner","sequence":"additional","affiliation":[{"name":"Department of Applied Psychology, Zurich University of Applied Sciences, Zurich, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002127"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3233\/JRS-180746"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181a5233f"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2023.0004"}],"container-title":["Journal of Child and Adolescent Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.liebertpub.com\/doi\/full-xml\/10.1089\/cap.2023.0029","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.liebertpub.com\/doi\/pdf\/10.1089\/cap.2023.0029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:56:43Z","timestamp":1777388203000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/cap.2023.0029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":4,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,9,1]]}},"alternative-id":["10.1089\/cap.2023.0029"],"URL":"https:\/\/doi.org\/10.1089\/cap.2023.0029","relation":{},"ISSN":["1044-5463","1557-8992"],"issn-type":[{"value":"1044-5463","type":"print"},{"value":"1557-8992","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}